PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer

BACKGROUND: Pancreatic cancer is one of the deadliest cancers, with low long-term survival rates. Despite recent advances in treatment, it is important to identify and screen high-risk individuals for cancer prevention. Familial pancreatic cancer (FPC) accounts for 4%–10% of pancreatic cancers. Seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Liotta, Lucia, Lange, Sebastian, Maurer, H. Carlo, Olive, Kenneth P., Braren, Rickmer, Pfarr, Nicole, Burger, Sebastian, Muckenhuber, Alexander, Jesinghaus, Moritz, Steiger, Katja, Weichert, Wilko, Friess, Helmut, Schmid, Roland, Algül, Hana, Jost, Philipp J., Ramser, Juliane, Fischer, Christine, Quante, Anne S., Reichert, Maximilian, Quante, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119201/
https://www.ncbi.nlm.nih.gov/pubmed/33764904
http://dx.doi.org/10.1172/jci.insight.141532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119201/
https://www.ncbi.nlm.nih.gov/pubmed/33764904
http://dx.doi.org/10.1172/jci.insight.141532

Ejemplares similares